explore -WSS

explore

author：Wikipedia 2025-10-02 20:59:37 - browse：5

Paul Biondi Flagship

Pharma giant Pfizer is turning to venture firm Flagship for new drug development, signing a deal worth up to $7 billion to mine new medicines from the latter’s portfolio companies.

Flagship and Pfizer announced Tuesday that they will each put $50 million into developing up to 10 drug candidates. Pfizer will have first rights to acquire each for up to $700 million, plus royalties. Flagship’s portfolio companies will also share in any payments that come out of the partnership.

Flagship has historically developed new medicines by forming and spinning out startup companies, some of which have signed their own collaboration deals with the likes of Amgen or Nestlé Health Science. But in recent years, the firm has been pursuing external partnerships through a new business division called Pioneering Medicines, led by former Bristol Myers Squibb executive Paul Biondi. Pioneering Medicines uses technologies and other scientific platforms being developed by Flagship’s portfolio companies to look for possible therapies in disease areas that the startup may not be working in.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Sports medicine is finally prioritizing gender equality
Next article： Our daughter's deadly disease: trisomy 18. We wanted to protect her

knowledge

WSS

Why an extreme heat and wildfire smoke combination can be so dangerous

Organ transplantation is at a crossroads. Major reform is needed

Google and Epic fight stronger regulation of AI in health care

Hyaluronic acid injections don’t help knee osteoarthritis, study finds

Southern California school board OKs curriculum after Gov. Gavin Newsom threatened a $1.5M fine

New rules on organ donation and transplantation 'will bring chaos'

focus

explore

explore

Medicare details structure of new drug price negotiation program

Elizabeth Warren probes abortion access

Supreme Court strikes down use of affirmative action

Sanders adds drug shortage policies to pandemic preparedness bill

How one medical school became remarkably diverse

Body of missing toddler recovered in Delaware River days after flood: Police

Walensky prepares to leave CDC — and Congress — behind

At Orexo, a ‘turning point’ for everything but digital health

Drug repurposing or repositioning? The language matters

In early work, researchers turn to CRISPR to treat Alzheimer's

leisure time

Medicare has a new plan to address drug shortages

New rules on organ donation and transplantation 'will bring chaos'

Elizabeth Warren probes abortion access

How dance can help nurses traumatized by Covid

In early work, researchers turn to CRISPR to treat Alzheimer's

Why an extreme heat and wildfire smoke combination can be so dangerous

knowledge

knowledge

leisure time

focus